scispace - formally typeset
P

Patrizia Porcu

Researcher at National Research Council

Publications -  58
Citations -  2647

Patrizia Porcu is an academic researcher from National Research Council. The author has contributed to research in topics: Neuroactive steroid & Allopregnanolone. The author has an hindex of 25, co-authored 54 publications receiving 2298 citations. Previous affiliations of Patrizia Porcu include University of California, San Diego & Oregon National Primate Research Center.

Papers
More filters
Journal ArticleDOI

Role of brain allopregnanolone in the plasticity of gamma -aminobutyric acid type a receptor in rat brain during pregnancy and after delivery

TL;DR: The results indicate that the plasticity of GABAA receptors during pregnancy and after delivery is functionally related to fluctuations in endogenous brain concentrations of AP whose rate of synthesis/metabolism appears to differ in the brain, compared with plasma, in pregnant rats.
Journal ArticleDOI

The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress.

TL;DR: The elucidation of the mechanisms that underlie adaptations to ethanol exposure are leading to a better understanding of the regulation of inhibitory transmission and new targets for therapies to support recovery from ethanol withdrawal and alcoholism.
Journal ArticleDOI

Neurosteroidogenesis today: Novel targets for neuroactive steroid synthesis and action and their relevance for translational research.

TL;DR: This review summarises recent approaches that target the neuroactive steroid biosynthetic pathway at different levels aiming to promote neurosteroidogenesis, which may be beneficial not only for neurodegenerative diseases, such as Alzheimer's disease and age‐related dementia, but also for neuropsychiatric diseases, including alcohol use disorders.
Journal ArticleDOI

Changes in GABAA receptor γ2 subunit gene expression induced by long-term administration of oral contraceptives in rats

TL;DR: Results indicate that long-term treatment with OCs induced a persistent reduction in the concentrations of pregnenolone, progesterone and its GABA(A) receptor-active metabolite, allopregnanolones, both in rats and women.